Jefferies lowered the firm’s price target on National Health Investors (NHI) to $66 from $77 and keeps a Hold rating on the shares as part of a 2025 outlook. Within healthcare real estate investment trusts, the firm prefers senior housing, saying deliveries are “muted” while the 80-plus population is entering a high-growth period. Ventas (VTR) is the analyst’s top pick, and it is also positive on Welltower (WELL) and Sabra Health Care REIT (SBRA). Within the other subsectors, Jefferies prefers REITs that are well positioned to “flex external growth” in 2025 like Caretrust REIT (CTRE) and Healthpeak Properties (DOC).
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- National Health Investors price target lowered to $72 from $78 at Truist
- National Health Investors price target lowered to $76 from $80 at Wells Fargo
- National Health Investors price target lowered to $91 from $92 at BofA
- Navigating Risks: National Health Investors’ Potential Exposure in Forward Sale Agreements
- National Health Investors Reports Q3 2024 Results